Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Lucilla Bongiorno-Borbone"'
Autor:
Isabella Orienti, Valentina Salvati, Giovanni Sette, Massimo Zucchetti, Lucilla Bongiorno-Borbone, Angelo Peschiaroli, Lello Zolla, Federica Francescangeli, Mariella Ferrari, Cristina Matteo, Ezia Bello, Antonio Di Virgilio, Mario Falchi, Maria Laura De Angelis, Marta Baiocchi, Gerry Melino, Ruggero De Maria, Ann Zeuner, Adriana Eramo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-17 (2019)
Abstract Background An increasing number of anticancer agents has been proposed in recent years with the attempt to overcome treatment-resistant cancer cells and particularly cancer stem cells (CSC), the major culprits for tumour resistance and recur
Externí odkaz:
https://doaj.org/article/4a12c3bc432f4836b5239c7374f87fc0
Autor:
Veronica Gatti, Lucilla Bongiorno-Borbone, Claudia Fierro, Margherita Annicchiarico-Petruzzelli, Gerry Melino, Angelo Peschiaroli
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 11, p 2683 (2019)
After lung cancer, breast cancer (BC) is the most frequent cause of cancer death among women, worldwide. Although advances in screening approaches and targeted therapeutic agents have decreased BC incidence and mortality, over the past five years, tr
Externí odkaz:
https://doaj.org/article/cd149ee55ede4c7c9479e15add8a5d22
Autor:
Angelita Costantino, Angelo Peschiaroli, Gerry Melino, Marco Tartaglia, Maria Laura De Angelis, Lucilla Bongiorno-Borbone, Marta Baiocchi, Alessandro Giuliani, Michele Signore, Alessandra Boe, Adriana Eramo, Ruggero De Maria, Alessandro Bruselles, Ann Zeuner, Paola Contavalli, Isabella Orienti, Federica Francescangeli, Toshio Kitamura, Massimo Spada, Filippo La Torre, Valentina Salvati, Giovanni Sette, Toshihiko Oki, Lello Zolla, Katia Fecchi
Publikováno v:
Cell death and disease 10 (2019). doi:10.1038/s41419-019-1775-y
info:cnr-pdr/source/autori:Orienti, Isabella; Francescangeli, Federica; De Angelis, Maria Laura; Fecchi, Katia; Bongiorno-Borbone, Lucilla; Signore, Michele; Peschiaroli, Angelo; Boe, Alessandra; Bruselles, Alessandro; Costantino, Angelita; Eramo, Adriana; Salvati, Valentina; Sette, Giovanni; Contavalli, Paola; Zolla, Lello; Oki, Toshihiko; Kitamura, Toshio; Spada, Massimo; Giuliani, Alessandro; Baiocchi, Marta; La Torre, Filippo; Melino, Gerry; Tartaglia, Marco; De Maria, Ruggero; Zeuner, Ann/titolo:A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors/doi:10.1038%2Fs41419-019-1775-y/rivista:Cell death and disease/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume:10
Cell Death and Disease, Vol 10, Iss 7, Pp 1-19 (2019)
Cell Death & Disease
info:cnr-pdr/source/autori:Orienti, Isabella; Francescangeli, Federica; De Angelis, Maria Laura; Fecchi, Katia; Bongiorno-Borbone, Lucilla; Signore, Michele; Peschiaroli, Angelo; Boe, Alessandra; Bruselles, Alessandro; Costantino, Angelita; Eramo, Adriana; Salvati, Valentina; Sette, Giovanni; Contavalli, Paola; Zolla, Lello; Oki, Toshihiko; Kitamura, Toshio; Spada, Massimo; Giuliani, Alessandro; Baiocchi, Marta; La Torre, Filippo; Melino, Gerry; Tartaglia, Marco; De Maria, Ruggero; Zeuner, Ann/titolo:A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors/doi:10.1038%2Fs41419-019-1775-y/rivista:Cell death and disease/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume:10
Cell Death and Disease, Vol 10, Iss 7, Pp 1-19 (2019)
Cell Death & Disease
Fenretinide is a synthetic retinoid characterized by anticancer activity in preclinical models and favorable toxicological profile, but also by a low bioavailability that hindered its clinical efficacy in former clinical trials. We developed a new fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a899c2edee4635b1f6baaf7a2ba6a6
Autor:
Giovanni Sette, Lello Zolla, Gerry Melino, Angelo Peschiaroli, Federica Francescangeli, Mariella Ferrari, Maria Laura De Angelis, Cristina Matteo, Ezia Bello, Antonio Di Virgilio, Massimo Zucchetti, Valentina Salvati, Mario Falchi, Isabella Orienti, Marta Baiocchi, Adriana Eramo, Ruggero De Maria, Ann Zeuner, Lucilla Bongiorno-Borbone
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Journal of experimental & clinical cancer research (Online) 38 (2019). doi:10.1186/s13046-019-1383-9
info:cnr-pdr/source/autori:Orienti, Isabella; Salvati, Valentina; Sette, Giovanni; Zucchetti, Massimo; Bongiorno-Borbone, Lucilla; Peschiaroli, Angelo; Zolla, Lello; Francescangeli, Federica; Ferrari, Mariella; Matteo, Cristina; Bello, Ezia; Di Virgilio, Antonio; Falchi, Mario; De Angelis, Maria Laura; Baiocchi, Marta; Melino, Gerry; De Maria, Ruggero; Zeuner, Ann; Eramo, Adriana/titolo:A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells/doi:10.1186%2Fs13046-019-1383-9/rivista:Journal of experimental & clinical cancer research (Online)/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume:38
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-17 (2019)
Journal of experimental & clinical cancer research (Online) 38 (2019). doi:10.1186/s13046-019-1383-9
info:cnr-pdr/source/autori:Orienti, Isabella; Salvati, Valentina; Sette, Giovanni; Zucchetti, Massimo; Bongiorno-Borbone, Lucilla; Peschiaroli, Angelo; Zolla, Lello; Francescangeli, Federica; Ferrari, Mariella; Matteo, Cristina; Bello, Ezia; Di Virgilio, Antonio; Falchi, Mario; De Angelis, Maria Laura; Baiocchi, Marta; Melino, Gerry; De Maria, Ruggero; Zeuner, Ann; Eramo, Adriana/titolo:A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells/doi:10.1186%2Fs13046-019-1383-9/rivista:Journal of experimental & clinical cancer research (Online)/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume:38
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-17 (2019)
Background An increasing number of anticancer agents has been proposed in recent years with the attempt to overcome treatment-resistant cancer cells and particularly cancer stem cells (CSC), the major culprits for tumour resistance and recurrence. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eb4fc89e25feeb0fbe91e57fe07b777
http://hdl.handle.net/11573/1336618
http://hdl.handle.net/11573/1336618
Autor:
Veronica Gatti, Lucilla Bongiorno-Borbone, Angelo Peschiaroli, Elke Markert, Claudia Fierro, Gerry Melino, Mirco Compagnone, Federica Giangrazi
Publikováno v:
Oncogenesis 7 (2018). doi:10.1038/s41389-018-0073-3
info:cnr-pdr/source/autori:Gatti V.; Fierro C.; Compagnone M.; Giangrazi F.; Markert E.K.; Bongiorno-Borbone L.; Melino G.; Peschiaroli A./titolo:?Np63 regulates the expression of hyaluronic acid-related genes in breast cancer cells/doi:10.1038%2Fs41389-018-0073-3/rivista:Oncogenesis/anno:2018/pagina_da:/pagina_a:/intervallo_pagine:/volume:7
Oncogenesis, Vol 7, Iss 8, Pp 1-9 (2018)
Oncogenesis
info:cnr-pdr/source/autori:Gatti V.; Fierro C.; Compagnone M.; Giangrazi F.; Markert E.K.; Bongiorno-Borbone L.; Melino G.; Peschiaroli A./titolo:?Np63 regulates the expression of hyaluronic acid-related genes in breast cancer cells/doi:10.1038%2Fs41389-018-0073-3/rivista:Oncogenesis/anno:2018/pagina_da:/pagina_a:/intervallo_pagine:/volume:7
Oncogenesis, Vol 7, Iss 8, Pp 1-9 (2018)
Oncogenesis
Triple negative breast cancers (TNBC) represent the most aggressive and clinically relevant breast carcinomas. On the basis of specific molecular signature, the majority of TNBC can be classified as basal-like breast carcinoma. Here, we report data s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbc5402cd6087a0753432698f2978a23
http://www.scopus.com/record/display.url?eid=2-s2.0-85052122661&origin=inward
http://www.scopus.com/record/display.url?eid=2-s2.0-85052122661&origin=inward
Autor:
Lucia Anemone, Gerry Melino, Giovina Ruberti, Veronica Gatti, Lucilla Bongiorno-Borbone, Huiqing Zhou, Alessandro Mauriello, Karen H. Vousden, Elke Markert, Claudia Fierro, Angelo Peschiaroli, Dario Presutti, Mirco Compagnone
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America 114 (2017): 13254–13259. doi:10.1073/pnas.1711777114
info:cnr-pdr/source/autori:Compagnone, Mirco; Gatti, Veronica; Presutti, Dario; Ruberti, Giovina; Fierro, Claudia; Markert, Elke Katrin; Vousden, Karen H.; Zhou, Huiqing; Mauriello, Alessandro; Anemone, Lucia; Bongiorno-Borbone, Lucilla; Melino, Gerry; Peschiaroli, Angelo/titolo:Delta Np63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis/doi:10.1073%2Fpnas.1711777114/rivista:Proceedings of the National Academy of Sciences of the United States of America/anno:2017/pagina_da:13254/pagina_a:13259/intervallo_pagine:13254–13259/volume:114
Proceedings of the National Academy of Sciences USA, 114, 50, pp. 13254-13259
Proceedings of the National Academy of Sciences USA, 114, 13254-13259
info:cnr-pdr/source/autori:Compagnone, Mirco; Gatti, Veronica; Presutti, Dario; Ruberti, Giovina; Fierro, Claudia; Markert, Elke Katrin; Vousden, Karen H.; Zhou, Huiqing; Mauriello, Alessandro; Anemone, Lucia; Bongiorno-Borbone, Lucilla; Melino, Gerry; Peschiaroli, Angelo/titolo:Delta Np63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis/doi:10.1073%2Fpnas.1711777114/rivista:Proceedings of the National Academy of Sciences of the United States of America/anno:2017/pagina_da:13254/pagina_a:13259/intervallo_pagine:13254–13259/volume:114
Proceedings of the National Academy of Sciences USA, 114, 50, pp. 13254-13259
Proceedings of the National Academy of Sciences USA, 114, 13254-13259
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, and several molecular pathways that underlie the molecular tumorigenesis of HNSCC have been identified. Among them, amplification or overexpression of Delta Np63
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fa29c721f444887bacfb0436f25dc09
http://hdl.handle.net/2108/204065
http://hdl.handle.net/2108/204065
Autor:
Anna Maria Timperio, Lello Zolla, Cristina Marrocco, Sara Rinalducci, Alessandro Finazzi Agrò, Lucilla Bongiorno-Borbone, Angelo Peschiaroli, Angelo D'Alessandro, Gerry Melino
Publikováno v:
Journal of proteome research
12 (2013): 4207–4220. doi:10.1021/pr4005508
info:cnr-pdr/source/autori:D'Alessandro Angelo1; Marrocco Cristina1; Rinalducci Sara1; Peschiaroli Angelo2; Timperio Anna Maria1; Bongiorno-Borbone Lucilla3; Finazzi Agrò Alessandro3; Melino Gerry3-4; Zolla Lello1/titolo:Analysis of TAp73-Dependent Signaling via Omics Technologies/doi:10.1021%2Fpr4005508/rivista:Journal of proteome research (Print)/anno:2013/pagina_da:4207/pagina_a:4220/intervallo_pagine:4207–4220/volume:12
12 (2013): 4207–4220. doi:10.1021/pr4005508
info:cnr-pdr/source/autori:D'Alessandro Angelo1; Marrocco Cristina1; Rinalducci Sara1; Peschiaroli Angelo2; Timperio Anna Maria1; Bongiorno-Borbone Lucilla3; Finazzi Agrò Alessandro3; Melino Gerry3-4; Zolla Lello1/titolo:Analysis of TAp73-Dependent Signaling via Omics Technologies/doi:10.1021%2Fpr4005508/rivista:Journal of proteome research (Print)/anno:2013/pagina_da:4207/pagina_a:4220/intervallo_pagine:4207–4220/volume:12
Transactivation-proficient (TA) p73 is a transcription factor belonging to the p53 family, which regulates a variety of biological processes, including neurogenesis, differentiation, apoptosis, and DNA damage checkpoint response. In the present study
Autor:
Alexey V. Antonov, E K Markert, J H Zhou, Angelo Peschiaroli, Gennaro Melino, Mirco Compagnone, Margherita Annicchiarico-Petruzzelli, Arianna Giacobbe, Lucilla Bongiorno-Borbone
Publikováno v:
Oncogene (Basingstoke) 35 (2016): 1602–1608. doi:10.1038/onc.2015.230
info:cnr-pdr/source/autori:Giacobbe, A.; Compagnone, M.; Bongiorno-Borbone, L.; Antonov, A.; Markert, E. K.; Zhou, J. H.; Annicchiarico-Petruzzelli, M.; Melino, G.; Peschiaroli, A./titolo:p63 controls cell migration and invasion by transcriptional regulation of MTSS1/doi:10.1038%2Fonc.2015.230/rivista:Oncogene (Basingstoke)/anno:2016/pagina_da:1602/pagina_a:1608/intervallo_pagine:1602–1608/volume:35
info:cnr-pdr/source/autori:Giacobbe, A.; Compagnone, M.; Bongiorno-Borbone, L.; Antonov, A.; Markert, E. K.; Zhou, J. H.; Annicchiarico-Petruzzelli, M.; Melino, G.; Peschiaroli, A./titolo:p63 controls cell migration and invasion by transcriptional regulation of MTSS1/doi:10.1038%2Fonc.2015.230/rivista:Oncogene (Basingstoke)/anno:2016/pagina_da:1602/pagina_a:1608/intervallo_pagine:1602–1608/volume:35
Metastasis is a multistep cell-biological process, which is orchestrated by many factors, including metastasis activators and suppressors. Metastasis Suppressor 1 (MTSS1) was originally identified as a metastasis suppressor protein whose expression i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9758958bf2ee5ed020ab57cb0259107b
http://hdl.handle.net/2108/239692
http://hdl.handle.net/2108/239692
Autor:
Ruggero De Maria, Mirco Compagnone, Angelo Peschiaroli, Adriana Eramo, Gerry Melino, Arianna Giacobbe, Lucilla Bongiorno-Borbone
Publikováno v:
Oncotarget
Europe PubMed Central
Aging (Albany NY)
Oncotarget 6 (2015): 16926–16938. doi:10.18632/oncotarget.4700
info:cnr-pdr/source/autori:Bongiorno-Borbone, Lucilla; Giacobbe, Arianna; Compagnone, Mirco; Eramo, Adriana; De Maria, Ruggero; Peschiaroli, Angelo; Melino, Gerry/titolo:Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells/doi:10.18632%2Foncotarget.4700/rivista:Oncotarget/anno:2015/pagina_da:16926/pagina_a:16938/intervallo_pagine:16926–16938/volume:6
Europe PubMed Central
Aging (Albany NY)
Oncotarget 6 (2015): 16926–16938. doi:10.18632/oncotarget.4700
info:cnr-pdr/source/autori:Bongiorno-Borbone, Lucilla; Giacobbe, Arianna; Compagnone, Mirco; Eramo, Adriana; De Maria, Ruggero; Peschiaroli, Angelo; Melino, Gerry/titolo:Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells/doi:10.18632%2Foncotarget.4700/rivista:Oncotarget/anno:2015/pagina_da:16926/pagina_a:16938/intervallo_pagine:16926–16938/volume:6
Lung cancer is the most feared of all cancers because of its heterogeneity and resistance to available treatments. Cancer stem cells (CSCs) are the cell population responsible for lung cancer chemoresistance and are a very good model for testing new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a45ffda442377a5a9f7a64db3f517652
http://hdl.handle.net/2108/240140
http://hdl.handle.net/2108/240140
Autor:
Eliana Munarriz, Daniela Barcaroli, Richard A. Knight, Michael H Neale, V De Laurenzi, Gerry Melino, E. Fava, T. M. Smith, A E Sayan, J. M. McWilliam, David Dinsdale, Lucilla Bongiorno-Borbone, Marco Ranalli
Publikováno v:
Proceedings of the National Academy of Sciences. 103:14802-14807
Cajal bodies are small nuclear organelles with a number of nuclear functions. Here we show that FLICE-associated huge protein (FLASH), originally described as a component of the apoptosis signaling pathway, is mainly localized in Cajal bodies and is